Elan (ELN +3.6%) gains after Deutsche upped the shares to Buy earlier today, citing optimism...


Elan (ELN +3.6%) gains after Deutsche upped the shares to Buy earlier today, citing optimism over the company's pending FY12 data release for its Alzheimer’s disease treatment bapineuzumab.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs